ምርጥ PGT-A/PGT-M (የፅንስ የዘረመል ምርመራ) ዶክተሮች በጉሩግራም

PGT-M does not automatically include PGT-A screening unless both tests are ordered together. PGT-M checks for monogenic disorders, which are single-gene inherited conditions. PGT-A screens for aneuploidy, which is an abnormal number of chromosomes in an embryo. Fertility specialists often combine both techniques during one embryo biopsy cycle to assess genetic health thoroughly.

The appropriate genetic test depends on your personal medical history and specific family risk factors. PGT-A checks general chromosome numbers to help select viable embryos for transfer. PGT-M targets single-gene inherited conditions passed down through family lines. Reproductive specialists review your genetic background to recommend single or combined testing. This helps ensure suitable embryo selection.

PGT-M testing provides high accuracy for identifying specific single-gene inherited conditions in embryos. The process uses advanced molecular techniques to analyze genetic material taken from embryonic cells. Laboratories run strict controls to prevent errors such as allele dropout, which is missing gene detection. Your medical team reviews lab quality controls before proceeding with transfer.

An embryo biopsy removes a few cells from the trophectoderm, which is the embryo outer cell layer. This procedure occurs on day five or six of embryo development in the laboratory. The inner cell mass forming the fetus remains untouched during this sampling process. The extracted cells undergo genetic analysis while the embryo is safely frozen.

Embryo biopsy carries a small risk, but skilled embryologists minimize potential harm using precise laser tools. Removing a few trophectoderm cells from the outer layer does not disrupt future fetal development. Surviving frozen embryos continue to develop normally after successful biopsy procedures. Laboratories maintain strict freezing protocols to safeguard embryo viability.

Genetic analysis results for PGT typically take between two and three weeks to complete. After the embryologist biopsies the cells, the genetic samples travel to a specialized testing laboratory. The remaining embryos stay safely cryopreserved, which is frozen in liquid nitrogen, at the clinic. Your doctor contacts you to review genetic reports once analysis finishes.

Overall treatment costs depend on the number of embryos tested and the specific screening required. Testing for monogenic conditions often requires custom probe creation, which adds administrative and laboratory work. Hospital fees, embryo freezing costs, and medication needs also affect the total budget. Patients should request an itemized quotation before starting their treatment plan.

International patients should coordinate travel timing based on ovarian stimulation and embryo biopsy schedules. The initial phase involves hormone injections and egg retrieval, which requires staying near the clinic. Embryo biopsy and genetic analysis take several weeks, allowing patients to return home while waiting. A separate short trip is planned later for the frozen embryo transfer.

Patients need complete medical records, past IVF cycle summaries, and preliminary genetic test results. If undergoing PGT-M, diagnostic reports identifying the exact family gene mutation must be submitted beforehand. These documents allow the genetic laboratory to prepare necessary reagents before you travel. Having thorough documentation avoids delays and helps coordinate your care smoothly.